Exploring gene mutations with Oncogenomics Explorer – mutation types to function to co-occurrence
Acute myeloid leukemia (AML) is the most common acute leukemia among adults. Mutations in DNA (cytosine-5)-methyltransferase 3A (DNMT3A) has been linked to poor survival of AML patients1. Identification of DNMT3A and other co-occurring mutations might be a useful marker in patient prognosis but also in stratification of patients for targeted therapeutics.
How to search for DNMT3A...
MediSapiens to provide comprehensive bioinformatics application to Bayer HealthCare
Helsinki, April 22, 2014. MediSapiens Ltd, a Finnish company developing bioinformatics applications for the pharmaceutical industry, today announced that it will provide Bayer HealthCare with a new software solution for analysis and visualization of genomics data.
This software system, called the Integrated Genomics Platform, will serve as a centralised access to genomics data used throughout a...
Continuing our series of scientific cases that highlight the benefits and capabilities of our bioinformatics solutions, take a look at this month's case study, "Exploring gene mutations with Oncogenomics Explorer – mutation types from function to co-occurrence".
MediSapiens will be attending the BioIT World congress in Boston in April 29 - May 1. We warmly invite all our customers and collaborators to meet our team at the Boston Seaport World Trade Center for the year's premier event in software solutions and informatics to biomedical research and the drug discovery enterprise.
Additional information here.
MediSapiens ranked among the hottest startups in Finland
MediSapiens is extremely proud to be among the Top5 companies on the Trending Startups List .
The last few months we have been witnessing a tremendous increase of interest towards our software and we are honoured to join the Hottest Startups List along with such successful startups as Supercell, Jolla and Dealdash.
Our free gene expression visualisation tool, IST Online, is experiencing an unexpectedly heavy user load. Therefore, you may be experiencing trouble logging on to the site. We are currently working (feverishly) to increase its capacity, so please bear with us.
It seems we weren't quite prepared for so many users. Please excuse our dust.